These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12590585)

  • 1. Kinetic and docking studies of the interaction of quinones with the quinone reductase active site.
    Zhou Z; Fisher D; Spidel J; Greenfield J; Patson B; Fazal A; Wigal C; Moe OA; Madura JD
    Biochemistry; 2003 Feb; 42(7):1985-94. PubMed ID: 12590585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of NAD(P)H:quinone reductase: Ab initio studies of reduced flavin.
    Cavelier G; Amzel LM
    Proteins; 2001 Jun; 43(4):420-32. PubMed ID: 11340659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction.
    Li R; Bianchet MA; Talalay P; Amzel LM
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8846-50. PubMed ID: 7568029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-electron reduction of quinones by rat liver NAD(P)H:quinone oxidoreductase: quantitative structure-activity relationships.
    Anusevicius Z; Sarlauskas J; Cenas N
    Arch Biochem Biophys; 2002 Aug; 404(2):254-62. PubMed ID: 12147263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based development of anticancer drugs: complexes of NAD(P)H:quinone oxidoreductase 1 with chemotherapeutic quinones.
    Faig M; Bianchet MA; Winski S; Hargreaves R; Moody CJ; Hudnott AR; Ross D; Amzel LM
    Structure; 2001 Aug; 9(8):659-67. PubMed ID: 11587640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of (±)-dunnione and its ortho-quinone analogues as substrates for NAD(P)H:quinone oxidoreductase 1 (NQO1).
    Bian J; Xu L; Deng B; Qian X; Fan J; Yang X; Liu F; Xu X; Guo X; Li X; Sun H; You Q; Zhang X
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1244-8. PubMed ID: 25677663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure, function, and mechanism of cytosolic quinone reductases.
    Bianchet MA; Erdemli SB; Amzel LM
    Vitam Horm; 2008; 78():63-84. PubMed ID: 18374190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of nitroaromatic compounds by NAD(P)H:quinone oxidoreductase (NQO1): the role of electron-accepting potency and structural parameters in the substrate specificity.
    Miseviciene L; Anusevicius Z; Sarlauskas J; Cenas N
    Acta Biochim Pol; 2006; 53(3):569-76. PubMed ID: 16929382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of histidine-194, aspartate-163, and a glycine-rich sequence of NAD(P)H:quinone oxidoreductase in the interaction with nicotinamide coenzymes.
    Cui K; Ma Q; Lu AY; Yang CS
    Arch Biochem Biophys; 1995 Nov; 323(2):265-73. PubMed ID: 7487087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COMPARE analysis of the toxicity of an iminoquinone derivative of the imidazo[5,4-f]benzimidazoles with NAD(P)H:quinone oxidoreductase 1 (NQO1) activity and computational docking of quinones as NQO1 substrates.
    Fagan V; Bonham S; Carty MP; Saenz-Méndez P; Eriksson LA; Aldabbagh F
    Bioorg Med Chem; 2012 May; 20(10):3223-32. PubMed ID: 22522008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human NAD(P)H:quinone oxidoreductase type I (hNQO1) activation of quinone propionic acid trigger groups.
    Mendoza MF; Hollabaugh NM; Hettiarachchi SU; McCarley RL
    Biochemistry; 2012 Oct; 51(40):8014-26. PubMed ID: 22989153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of human quinone reductase type 2, a metalloflavoprotein.
    Foster CE; Bianchet MA; Talalay P; Zhao Q; Amzel LM
    Biochemistry; 1999 Aug; 38(31):9881-6. PubMed ID: 10433694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naphthoquinones, benzoquinones, and anthraquinones: Molecular docking, ADME and inhibition studies on human serum paraoxonase-1 associated with cardiovascular diseases.
    Demir Y
    Drug Dev Res; 2020 Aug; 81(5):628-636. PubMed ID: 32232985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the quinone reductase activity of the ferric reductase B protein from Paracoccus denitrificans.
    Sedlácek V; van Spanning RJ; Kucera I
    Arch Biochem Biophys; 2009 Mar; 483(1):29-36. PubMed ID: 19138657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-domain structure for the two subunits of NAD(P)H:quinone acceptor oxidoreductase.
    Chen S; Deng PS; Bailey JM; Swiderek KM
    Protein Sci; 1994 Jan; 3(1):51-7. PubMed ID: 7511454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzimidazole- and benzothiazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1.
    Newsome JJ; Colucci MA; Hassani M; Beall HD; Moody CJ
    Org Biomol Chem; 2007 Nov; 5(22):3665-73. PubMed ID: 17971996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the mechanism of Type-II NADH: Quinone oxidoreductase from S. aureus.
    Sena FV; Sousa FM; Oliveira ASF; Soares CM; Catarino T; Pereira MM
    Redox Biol; 2018 Jun; 16():209-214. PubMed ID: 29524843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures of recombinant human and mouse NAD(P)H:quinone oxidoreductases: species comparison and structural changes with substrate binding and release.
    Faig M; Bianchet MA; Talalay P; Chen S; Winski S; Ross D; Amzel LM
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3177-82. PubMed ID: 10706635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A direct interaction between NQO1 and a chemotherapeutic dimeric naphthoquinone.
    Pidugu LS; Mbimba JC; Ahmad M; Pozharski E; Sausville EA; Emadi A; Toth EA
    BMC Struct Biol; 2016 Jan; 16():1. PubMed ID: 26822308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lavendamycin antitumor agents: structure-based design, synthesis, and NAD(P)H:quinone oxidoreductase 1 (NQO1) model validation with molecular docking and biological studies.
    Hassani M; Cai W; Koelsch KH; Holley DC; Rose AS; Olang F; Lineswala JP; Holloway WG; Gerdes JM; Behforouz M; Beall HD
    J Med Chem; 2008 Jun; 51(11):3104-15. PubMed ID: 18457384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.